Yvanne Enever, Founder/CEO reflects on 2021

Tuesday, January 4th, 2022

We are pleased to say that 2021 has seen PHARMExcel busier than ever. From delivering the Worlds’ first Booster Vaccine clinical trial leading to the shaping of UK Government policy, to welcoming new, key staff appointments and undertaking several charity events for Macmillan Cancer Support, Team PHARMExcel showed dedication to the cause. As we complete…

Read More

PHARMExcel delighted to be the selected U.K. CRO delivering this pivotal clinical trial alongside colleagues at University Southampton, Cambridge and DIOSynVax.

Friday, December 17th, 2021

Read More

PHARMExcel are pleased to announce the publication of the safety and immunogenicity data from the UK’s Covboost trial.

Monday, December 6th, 2021

Read More

Covid booster jabs will begin to be offered across the UK from next week based on JCVI decisions following COVBoost clinical trial data.

Wednesday, September 15th, 2021

Read More

PHARMExcel, a U.K. based CRO, is delighted to have been selected as the CRO to support the COVBoost study. Data has contributed to the MHRA approval decisions

Thursday, September 9th, 2021

Read More

PHARMExcel supports recruitment of the first patient into INmuneBio’s pivotal MDS study showing promising results

Wednesday, August 25th, 2021

Read More

Initial covboost study data ready for analysis..

Tuesday, August 3rd, 2021

Read More

PHARMExcel running MDS trial that sees first patient treated

Monday, July 12th, 2021

Read More

Covid: Bradford NHS consultant first in world to receive booster vaccine

Wednesday, June 2nd, 2021

Read More